Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial

J Gastroenterol. 2024 Apr;59(4):358. doi: 10.1007/s00535-024-02085-z. Epub 2024 Feb 14.

Authors

Yu Huang¹, Hong Lu²

Affiliations

¹ Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
² Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. hlu@sjtu.edu.cn.

PMID: 38353808
DOI: 10.1007/s00535-024-02085-z

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Amoxicillin / therapeutic use
Anti-Bacterial Agents / therapeutic use
Bismuth / therapeutic use
Drug Therapy, Combination
Helicobacter Infections* / drug therapy
Helicobacter pylori*
Humans
Minocycline / therapeutic use
Multicenter Studies as Topic
Proton Pump Inhibitors / therapeutic use
Randomized Controlled Trials as Topic
Tetracycline / therapeutic use
Treatment Outcome

Substances

Amoxicillin
Anti-Bacterial Agents
Bismuth
Minocycline
Proton Pump Inhibitors
Tetracycline

Grants and funding